Overview

matrilysin


'matrilysin' can also refer to...

matrilysin

matrilysin

Clinicopathologic and Prognostic Significance of MMP-7 (Matrilysin) Expression in Human Rectal Cancer

Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice

Inhibitory Effects of Green Tea Catechins on the Activity of Human Matrix Metalloproteinase 7 (Matrilysin)

Interactions of Human Matrix Metalloproteinase 7 (Matrilysin) with the Inhibitors Thiorphan and R-94138

Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer

Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas

Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma

Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin

Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen

States of Tryptophyl Residues and Stability of Recombinant Human Matrix Metalloproteinase 7 (Matrilysin) as Examined by Fluorescence

Refolding and Recovery of Recombinant Human Matrix Metalloproteinase 7 (Matrilysin) from Inclusion Bodies Expressed by Escherichia coli

Purification and Refolding of Recombinant Human proMMP-7 (pro-Matrilysin) Expressed inEscherichia coli and Its Characterization

Effects of Dimethyl Sulfoxide, Temperature, and Sodium Chloride on the Activity of Human Matrix Metalloproteinase 7 (Matrilysin)

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

A matrix metallopeptidases (MMP-7, EC 3.4.24.23, 267 aa) involved in tissue remodelling and in the cellular invasion of tissues. Matrilysin-2 is MMP-26.

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.